Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Head and Neck Neoplasms 4Hot Flashes 3Breast Neoplasms 3Pain 2Vomiting 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neuralgia 1Neoplasms 1Nausea 1Mucositis 1Lung Neoplasms 1Abnormalities, Radiation-Induced 1

Interventions

Radiotherapy 8Zoledronic Acid 7Fentanyl 7nabiximols 6Morphine 6Ibandronic Acid 6Ketamine 5Hydromorphone 5Analgesia 5Acetaminophen 5Tapentadol 4Oxycodone 4Acupuncture Therapy 4alvimopan 3Ropivacaine 3Prednisone 3Lidocaine 3cabozantinib 2Tetrodotoxin 2Mitoxantrone 2Gabapentin 2Duloxetine Hydrochloride 2Docetaxel 2Calcium 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2strontium chloride 1resiniferatoxin 1oxycodone-acetaminophen 1oxycodone naloxone combination 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Pain × Gabapentin × Clear all
NCT01067144 2022-05-05

Stanford Accelerated Recovery Trial (START)

Stanford University

Phase 3 Terminated
422 enrolled 12 charts
BreastThoracic

Breast Neoplasms, Lung Neoplasms, Pain

NCT00027963 2016-07-04

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
100 enrolled

Pain, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡